Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
2003 1
2004 1
2009 1
2011 1
2012 2
2013 5
2014 7
2015 6
2016 5
2017 5
2018 1
2019 1
2020 3
2021 4
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Bril V, Szczudlik A, Vaitkus A, Rozsa C, Kostera-Pruszczyk A, Hon P, Bednarik J, Tyblova M, Köhler W, Toomsoo T, Nowak RJ, Mozaffar T, Freimer ML, Nicolle MW, Magnus T, Pulley MT, Rivner M, Dimachkie MM, Distad BJ, Pascuzzi RM, Babiar D, Lin J, Coll MQ, Griffin R, Mondou E. Bril V, et al. Among authors: tyblova m. Neurology. 2022 Oct 21:10.1212/WNL.0000000000201501. doi: 10.1212/WNL.0000000000201501. Online ahead of print. Neurology. 2022. PMID: 36270895
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubikova M, Tyblova M, Tesar A, Magda H, Daniela V, Irena R, Iveta N, Kristyna D, Pavel D, Jiri P, Stanislav V, Josef B. Jakubikova M, et al. Among authors: tyblova m. Eur J Neurol. 2022 Jan;29(1):e7-e8. doi: 10.1111/ene.15158. Epub 2021 Nov 9. Eur J Neurol. 2022. PMID: 34699086 Free PMC article. No abstract available.
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection.
Stastna D, Menkyova I, Drahota J, Hrnciarova T, Kubala Havrdova E, Vachova M, Andelova M, Kleinova P, Kovarova I, Krasulova E, Preiningerova JL, Novakova I, Novotna K, Novotna M, Nytrova P, Pavlickova J, Srpova B, Storey K, Ticha V, Tyblova M, Uher T, Vodehnalova K, Horakova D. Stastna D, et al. Among authors: tyblova m. Mult Scler Relat Disord. 2022 Sep;65:104014. doi: 10.1016/j.msard.2022.104014. Epub 2022 Jul 2. Mult Scler Relat Disord. 2022. PMID: 35803085 Free PMC article.
Monitoring of radiologic disease activity by serum neurofilaments in MS.
Uher T, Schaedelin S, Srpova B, Barro C, Bergsland N, Dwyer M, Tyblova M, Vodehnalova K, Benkert P, Oechtering J, Leppert D, Naegelin Y, Krasensky J, Vaneckova M, Kubala Havrdova E, Kappos L, Zivadinov R, Horakova D, Kuhle J, Kalincik T. Uher T, et al. Among authors: tyblova m. Neurol Neuroimmunol Neuroinflamm. 2020 Apr 9;7(4):e714. doi: 10.1212/NXI.0000000000000714. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32273481 Free PMC article.
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
Uher T, Vaneckova M, Krasensky J, Sobisek L, Tyblova M, Volna J, Seidl Z, Bergsland N, Dwyer MG, Zivadinov R, De Stefano N, Sormani MP, Havrdova EK, Horakova D. Uher T, et al. Among authors: tyblova m. Mult Scler. 2019 Apr;25(4):541-553. doi: 10.1177/1352458517742739. Epub 2017 Nov 16. Mult Scler. 2019. PMID: 29143562
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
McComb M, Krikheli M, Uher T, Browne RW, Srpova B, Oechtering J, Maceski AM, Tyblova M, Jakimovski D, Ramasamy DP, Bergsland N, Krasensky J, Noskova L, Fialova L, Weinstock-Guttman B, Havrdova EK, Vaneckova M, Zivadinov R, Horakova D, Kuhle J, Ramanathan M. McComb M, et al. Among authors: tyblova m. J Clin Lipidol. 2020 Sep-Oct;14(5):675-684.e2. doi: 10.1016/j.jacl.2020.07.001. Epub 2020 Jul 9. J Clin Lipidol. 2020. PMID: 32758395
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubíková M, Týblová M, Tesař A, Horáková M, Vlažná D, Ryšánková I, Nováková I, Dolečková K, Dušek P, Piťha J, Voháňka S, Bednařík J. Jakubíková M, et al. Among authors: tyblova m. Eur J Neurol. 2021 Oct;28(10):3418-3425. doi: 10.1111/ene.14951. Epub 2021 Jun 25. Eur J Neurol. 2021. PMID: 34080271 Free PMC article.
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Uher T, McComb M, Galkin S, Srpova B, Oechtering J, Barro C, Tyblova M, Bergsland N, Krasensky J, Dwyer M, Havrdova EK, Posova H, Vaneckova M, Zivadinov R, Horakova D, Kuhle J, Ramanathan M. Uher T, et al. Among authors: tyblova m. Mult Scler. 2021 Feb;27(2):220-231. doi: 10.1177/1352458520912379. Epub 2020 Apr 7. Mult Scler. 2021. PMID: 32255388
40 results